Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1256 per EA under NDC 10702019001. Its NADAC has been published 450 times since Apr 11, 2018.

FDA first approved this application on Jun 21, 2017. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1256per EA
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

Manufacturer

KVK-Tech Inc.

NDC

10702019001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209037

FDA Approved

6/21/2017

TE Code

AA

On Market Since

6/22/2017

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 450 times since Apr 11, 2018, and over the history we have for it it has declined 16.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1256 per EA
All-time high$0.1630 (Jul 10, 2024)
All-time low$0.0932 (Dec 18, 2019)
52-week high$0.1485
52-week low$0.1256
Median price$0.1316
Average price$0.1307
Largest weekly change+41.5% (Jan 22, 2020)
Weeks tracked450
Tracking sinceApr 11, 2018

Price History

1W

-3.8%

1M

-7.2%

3M

-9.1%

6M

-9.0%

1Y

-16.3%

3Y

-0.8%

5Y

+13.1%

All

-16.2%

Generic Alternatives

The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by KVK-Tech Inc., is $0.1256 per EA (NDC 10702019001), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 16.2%. It has been tracked across 450 weekly CMS publications since Apr 11, 2018.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since Apr 11, 2018, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0932 (Dec 18, 2019) to a high of $0.1630 (Jul 10, 2024), with a median of $0.1316 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

13 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 10702019001) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.